Precedence Research, a provider of market intelligence and healthcare analytics, is introducing its Cell and Gene Therapy (CGT) Intelligence Platform. Types of Intelligence the Platform Gathers The company describes the platform as a next-generation solution that converts complex and often and fragmented datasets into structured intelligence. Importantly, Precedence says that intelligence is provided at a decision-ready level, for the rapidly evolving landscape of advanced therapies. Ty...